Richards Timothy T. 4

What Happened

• Timothy T. Richards, a director of ClearPoint Neuro (CLPT), sold 5,415 shares on June 1, 2026 in a transaction that generated $65,901 (weighted average price $12.17).
• The sale was made to cover the tax liability from the vesting of 12,417 restricted stock units (RSUs) that vested on May 19, 2026. This was a sale (S) rather than a purchase — typically a routine tax-withholding trade rather than a directional investment bet.

Key Details

• Transaction date: 2026-06-01; Form 4 filed 2026-06-02 (appears timely).
• Shares sold: 5,415 at a weighted average price of $12.17; prices in the sale ranged from $12.04 to $12.47.
• Gross proceeds reported: $65,901.
• Reason noted (footnote): sale was to cover tax liability from vesting of 12,417 RSUs (grant dated May 22, 2025; vested May 19, 2026).
• Remaining shares from that vesting: 12,417 vested minus 5,415 sold = 7,002 shares retained from this grant (per footnote mechanics).
• Total shares owned after the transaction: not disclosed in this Form 4.
• Additional note (footnote): Reporting person can provide breakdown of number of shares sold at each price within the range on request.

Context

• This is a tax-withholding sale tied to RSU vesting (common practice); such sales generally reflect tax obligations, not necessarily a change in insider sentiment about the company.
• No option exercise, 10b5-1 plan, or gift was reported — the filing indicates the sale was to satisfy withholding obligations.